D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1

Hypertension Research

Volumn 36, Issue 8, 2013, Pages 684-690

  Lu, Quansheng ^a   Yang, Yu ^a   Villar, Van Anthony ^a   Asico, Laureano ^a   Jones, John E ^a   Yu, Peiying ^a   Li, Hewang ^a   Weinman, Edward J ^a   Eisner, Gilbert M ^b   Jose, Pedro A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

D5 dopamine receptor; heme oxygenase 1; NADPH oxidase; reactive oxygen species

Indexed keywords

DOPAMINE 5 RECEPTOR; FENOLDOPAM; HEME OXYGENASE 1; HEMIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HEART RATE; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SYSTOLIC BLOOD PRESSURE; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEK293 CELL LINE; HYPERTENSION; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; UPREGULATION; CELL STRAIN HEK293; DRUG EFFECT;

ANIMALS; BLOOD PRESSURE; DOPAMINE AGONISTS; FENOLDOPAM; HEK293 CELLS; HEME OXYGENASE-1; HUMANS; HYPERTENSION; MICE; MICE, KNOCKOUT; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D5; UP-REGULATION;

EID: 84881404314     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.9     Document Type: Article

References (45)

1. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2: 637-650. (Pubitemid 44655641)
2. Asghar M, Tayebati SK, Lokhandwala MF, Hussain T. Potential dopamine-1 receptor stimulation in hypertension management. Curr Hypertens Rep 2011; 13: 294-302.
3. Ortiz PA, Garvin JL. Intrarenal transport and vasoactive substances in hypertension. Hypertension 2001; 38: 621-624.
4. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182-217.
5. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med 2003; 228: 134-142. (Pubitemid 36187919)
6. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19: 233-246.
7. Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, Eisner GM, Dk Grandy, Carey RM, Soares-da-Silva P, Jose PA. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension 2006; 47: 288-295. (Pubitemid 43192004)
8. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 2001; 38: 303-308. (Pubitemid 34225656)
9. Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 2003; 16: 853-858. (Pubitemid 37204683)
10. Cohn DH, Shohat T, Yahav M, Ilan T, Rechavi G, King L, Shohat M. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am J Hum Genet 2000; 67: 647-651. (Pubitemid 30659595)
11. Cooper RS, Luke A, Zhu X, Kan D, Adeyemo A, Rotimi C, Bouzekri N, Ward R, Rorimi C. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 2002; 40: 629-633. (Pubitemid 35278597)
12. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young III WS, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 2002; 22: 10801-10810. (Pubitemid 36005154)
13. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006; 290: R96-R104.
14. Banki K, Hutter E, Gonchoroff NJ, Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occurs independently from activation of caspase in Fas signaling. J Immunol 1999; 162: 1466-1479. (Pubitemid 29307019)
15. Forman HJ, Torres M. Reactive oxygen species and cell signaling. Am J Respir Crit Care Med 2002; 166: S4-S8.
16. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am 2009; 93: 621-635.
17. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai RK, Sibley DR, Felder RA, Jose PA. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005; 288: H55-H61.
18. Quinn MT, Ammons MC, Deleo FR. The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci (Lond) 2006; 111: 1-20. (Pubitemid 44023407)
19. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 2010; 12: 135-142.
20. Wang D, Strandgaard S, Iversen J, Wilcox CS. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol 2009; 296: R195-R200.
21. Vanecková I, Kramer HJ, Novotná J, Kazdová L, Opocenský M, Bader M, Ganten D, Cervenka L. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats. Kidney Blood Press Res 2005; 28: 117-126. (Pubitemid 41201989)
22. Maines MD, Gibbs PE. 30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events. Biochem Biophys Res Commun 2005; 338: 568-577. (Pubitemid 41540604)
23. Peterson S, Frishman WH, Abraham NG. Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 2009; 17: 99-111.
24. Hosick PA, Stec DE. Heme oxygenase, a novel target for the treatment of hypertension and obesity? Am J Physiol Regul Integr Comp Physiol 2012; 302: R207-R214.
25. Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002; 234-235: 249-263. (Pubitemid 34777864)
26. Majid DS, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 2007; 34: 946-952. (Pubitemid 47083962)
27. Vera T, Kelsen S, Yanes LL, Reckelhoff JF, Stec DE. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1472-R1478. (Pubitemid 46557809)
28. Sabaawy HE, Zhang F, Nguyen X, Elhosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001; 38: 210-215. (Pubitemid 34224746)
29. Taillé C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M, Boczkowski J. Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 2004; 27: 28681-28688. (Pubitemid 38900152)
30. Lanone S, Bloc S, Foresti R, Almolki A, Taillé C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J. Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FA SE B J 2005; 13: 1890-1892. (Pubitemid 41598785)
31. Xia ZW, Li CE, Jin YX, Shi Y, Xu LQ, Zhong WW, Li YZ, Yu SC, Zhang ZL. Reduction of bilirubin by targeting human heme oxygenase-1 through siRNA. Exp Biol Med (Maywood) 2007; 232: 495-502. (Pubitemid 46524471)
32. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 1986; 261: 411-419. (Pubitemid 16103962)
33. Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, Jose PA. Ga12-and Ga13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41: 604-610.
34. Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension 2007; 49: 672-678.
35. Sikorsk EM, Hock T, Hill-Kapturczak N, Agarwal A. The story so far: molecular regulation of the heme oxygenase. Am J Physiol Renal Physiol 2004; 286: F425-F441. (Pubitemid 38233635)
36. Berger SP, Hunger M, Yard B, Schnuelle P, Van Der Woude FJ. Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney Int 2000; 58: 2314-2319.
37. Schmidt J, Mertz K, Morgan JI. Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes. Brain Res Mol Brain Res 1999; 10: 50-59.
38. Salahudeen AK, Yang M, Huang H, Dore S, Stec DE. Fenoldopam preconditioning: role of heme oxygenase-1 in protecting human tubular cells and rodent kidneys against cold-hypoxic injury. Transplantation 2011; 91: 176-182.
39. Hara H, Ohta M, Adachi T. Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway. J Neurosci Res 2006; 84: 860-866. (Pubitemid 44366687)
40. George LE, Lokhandwala MF, Asghar M. Novel role of NF-kB-p65 in antioxidant homeostasis in human kidney-2 cells. Am J Physiol Renal Physiol 2012; 302: F1440-F1446.
41. Zhang Z, Cui W, Li G, Yuan S, Xu D, Hoi MP, Lin Z, Dou J, Han Y, Lee SM. Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCa and PI3K/AKT signaling pathways. J Agric Food Chem 2012; 60: 8171-8182.
42. Kim KC, Kang KA, Zhang R, Piao MJ, Kim GY, Kang MY, Lee SJ, Lee NH, Surh YJ, Hyun JW. Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt. Int J Biochem Cell Biol 2010; 42: 297-305.
43. Lee YJ, Jeong HY, Kim YB, Lee YJ, Won SY, Shim JH, Cho MK, Nam HS, Lee SH. Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem Toxicol 2012; 50: 116-123.
44. Perreault ML, Jones-Tabah J, O'Dowd BF, George SR. A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex. Int J Neuropsychopharmacol 2012; 25: 1-7.
45. Asico L, Zhang X, Jiang J, Cabrera D, Escano CS, Sibley DR, Wang X, Yang Y, Mannon R, Jones JE, Armando I, Jose PA. Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol 2011; 22: 82-89.